Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases - Quiz - MDSpire

Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases

  • By

  • Tim Reese

  • Dennis Björk

  • Anne M H Longva

  • Kristian S Kiim

  • Maximilian Evers

  • Peter N Larsen

  • Nicolai A Schultz

  • Bård I Røsok

  • Ulrik Carling

  • Fredrik Holmquist

  • Gert Lindell

  • Per Sandström

  • Jörg Böcker

  • Stefan Gilg

  • Jennie Engstrand

  • Christian Sturesson

  • Karl J Oldhafer

  • Bergthor Björnsson

  • Ernesto Sparrelid

  • September 22, 2025

  • 0 min

Share

Original Source(s)

Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases

  • by Tim Reese, Dennis Björk, Anne M H Longva, Kristian S Kiim, Maximilian Evers, Peter N Larsen, Nicolai A Schultz, Bård I Røsok, Ulrik Carling, Fredrik Holmquist, Gert Lindell, Per Sandström, Jörg Böcker, Stefan Gilg, Jennie Engstrand, Christian Sturesson, Karl J Oldhafer, Bergthor Björnsson, Ernesto Sparrelid

  • September 22, 2025

Related Content

Fluoroscopy-guided removal of a migrated non-palpable implanon adherent to the ulnar nerve: a case report

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.

A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey